top of page

Paws, People, & Cancer

Here is some great information on health, cancer prevention, and cure.

***FOR EDUCATIONAL PURPOSES ONLY, CONSULT YOUR OWN MEDICAL DOCTOR. NOT A RECOMMENDATION, NOT MEDICAL ADVICE, DO YOUR OWN RESEARCH, GET EDUCATED!***

Top 10 Doctors and Researchers with Highest Profiles on Youtube/Internet Promoting Fenbendazole, Ivermectin, and Ketogenic Diet for Cancer Based on online Visibility

1.

Dr. John Campbell

Nurse Educator & Youtuber

3M+ Youtube Subscribers; videos on topic> 1M views each

Hosts videos on ivermectin/Fenbendazole for cancer reversal ( e.g., stage 4 prostate cases); inverviews experts like Dr. Makis; covers keto as metabolic therapy

2.

Dr. Thomas Seyfried

Professor, Boston College

100k+ Youtube views per lecture; cited in 2024 peer-reviewed protocols

Pioneer of "cancer as metabolic disease"; advocates ketogenic diets/fasting to starve glucose-dependent tumors; endorses Fenbendazole/ivermectin as glutamine

3.

Dr. William Makis

Oncologist & Researcher

50k+ X followers; articles shared 1M+ times; guest on Campbell's channel

Compiles 300+ Fenbendazole success stories; co-authors 2024 ivermectin/menbendazole/Fenbendazole protocol with keto; viral X posts on turbo cancers.

4.

Dr. Paul Marik

Critical Care Physician, FLCCC

20k+ X Followers; FLCCC reach 500k+; cited in Zerohedge/Orthomolecular medicine

Co-develops hybrid protocols (ivermectin 1mg/kg + Fenbendazole 300mg + keto diet); peer-reviewed 2024 paper on repurposed drugs for all cancer grades.

5.

Dr. Dominic D'Agostino

Neuroscientist, University of South Florida

50k+ X Followers; 100k+ Youtube views on keto-cancer clips

Research keto for cancer (e.g., enhancing mebendazole efficacy); discusses ivermectin/Fenbendazole synergy in podcasts; metabolic therapy expert.

6.

Dr. Kathleen Ruddy

Oncologist & Author

10k+ X followers; book/podcast reach 200k+

Documents ivermectin reversals in stage 4 cancers; integrates with keto; featured in Campbell videos and metabolic cancer forums.

7.

Dr. Syed Haider

Physician & Blogger

30k+ X followers; viral articles 500k+ reads

Promotes FLCCC-style protocols (Fenbendazole + ivermectin + keto)l; shares case reports on turbo cancers via Substack/X.

8.

Dr. Mark Scholz

Urologist, PCRI Founder

PCRI Youtube 50k+ Subscribers; videos 100k+ views

Discusses ivermectin/mebendazole for prostate cancer in Youtube seminars; explores Fenbendazole safety with keto.

9.

Dr. Ilyes Baghli

Researcher, Association Cancer et Métabolisme

Cited in 1M+ protocol shares; X/academic reach 50k+

Leads 2024 peer-reviewed protocol on ivermectin/Fenbendazole/mebendazole + keto for mitochondrial targeting.

10.

Dr. Pierrick Martinez

Researcher, Association Cancer et Métabolisme

Protocol downloads 100k+ featured in ZeroHedge

Co-authors hybrid orthomolecular protocols emphasizing keto/fasting with Fenbendazole/ivermectin for stem cell targeting.

Dr. Seyfried Cancer Researcher

Cancer expert, a must watch, he has a few books on Amazon

Press-Pulse Protocol by Dr Seyfried, stress the cancer cells, basic notes below, not inclusive.

Metabolic Management of Cancer (2025 Updated Summary)

Core Principle Cancer is a mitochondrial metabolic disease.

Therapeutic Target Glucose-Ketone Index (GKI) ≤ 2.0 (ideally ≤ 1.0)

Formula: GKI = blood glucose (mmol/L) ÷ blood ketones (mmol/L)

PHASE 1 – PREPARATION (1–2 weeks)

  • Medical clearance & baseline labs (CBC, CMP, tumor markers, DEXA scan) 

  • Calculate daily calories: 20–25 kcal/kg ideal body weight 

  • Protein: 0.8–1.2 g/kg lean body mass 

  • Carbs: < 20–50 g/day total 

  • Fat: remaining calories (usually 80–90%)

PHASE 2 – CHRONIC “PRESS” (ongoing, never stop)

  1. Calorie-Restricted Ketogenic Diet (KD-R) 

    • Fat sources: butter, ghee, olive oil, coconut/MCT oil, avocados, macadamia nuts, fatty fish, eggs 

    • Protein: moderate (beef, salmon, eggs; avoid excess) 

    • Carbs: leafy greens, broccoli, cauliflower, zucchini 

    • Intermittent fasting 16:8 or 18:6 encouraged

  2. Daily GKI monitoring (use Keto-Mojo or Precision Xtra)
    Target: Glucose 70–90 mg/dL (3.9–5.0 mmol/L) + Ketones ≥ 2.0 mmol/L 

  3. Electrolytes 

    • Sodium: 4–6 g/day 

    • Potassium: 3–4 g/day 

    • Magnesium: 400–600 mg/day

PHASE 3 – INTERMITTENT “PULSES” (start after 1–2 weeks stable ketosis) A. Glutamine-targeting drugs (choose one or cycle) 

  • Fenbendazole: 222–444 mg/day, 3 days ON / 4 days OFF 

  • OR Mebendazole: 100–500 mg/day (continuous or pulsed) 

  • Ivermectin: 0.4–1 mg/kg body weight, 2–3 days per week (e.g., Mon/Wed/Fri)

2. HYPERBARIC OXYGEN TERAPY, CHAMBER “HBOT” – Optional, but powerful

2.0–2.5 ATA, 90 minutes, 3 sessions/week

            Hard Chamber 2.2 to 2.8 - 5 times a week for cancer, full oxygen

C. Supporting agents (commonly added) 

  • Metformin: 500–1000 mg/day (extended release) 

  • Berberine: 500 mg 2–3×/day (if metformin not tolerated) 

  • Atorvastatin 10–20 mg/day (enhances ketone utilization) 

  • Vitamin D3: 5,000–10,000 IU/day (target blood level 80–120 ng/mL)

 

MONITORING SCHEDULE Daily: GKI (morning fasting)
Weekly: weight, blood pressure, ketone/glucose log
Monthly: full blood panel + tumor markers
Every 6–8 weeks: imaging (PET-CT or MRI with contrast)

 

SAMPLE DAILY SCHEDULE (70 kg person) Calories: ~1,400–1,600 kcal 

  • Breakfast: 3 eggs cooked in 2 tbsp butter + 1 avocado 

  • Lunch: 150 g salmon + 2 cups spinach sautéed in olive oil 

  • Dinner: 120 g ribeye + 100 g broccoli with 2 tbsp MCT oil 

  • Snacks (if needed): macadamia nuts, 85–90% dark chocolate
    Supplements taken with meals

IMPORTANT NOTES

  • Never combine chronic high-dose DON without medical supervision 

  • Fenbendazole + ivermectin are off-label for cancer; use only under physician guidance 

  • Protocol works best in early-to-mid stage disease or as adjuvant 

  • Cachexia (severe weight loss) is a contraindication – build reserves first

Primary References 

  • Seyfried TN. Cancer as a Metabolic Disease (2012) 

  • Seyfried et al. Press-pulse: a novel therapeutic strategy (2017) 

  • 2024–2025 case series & bioRxiv preprints on benzimidazoles + ivermectin

Oncology Group Istanbul Turkey Who follows Dr Seyfried protocols

https://chemothermia.com

Dr Seyfried Press Pulse Interviews Excellent Watch in order
Seyfried Cancer Research
Starving Cancer: Breaking Down Thomas Seyfried's Radical & Controversial Protocol
02:38:08
Cancer Breakthrough: The Metabolic Approach to Defeating Disease- Prof Thomas Seyfried
01:06:41
Dennis Stacey on his Press-Pulse Protocol: Terminal Cancer GONE! (Dr. Seyfrieds metabolic therapy)
56:49
Press-Pulse Presentation Clips of Dr. Seyfried & Dr. D'Agostino (Supercut)
13:16
116 Breaking Cancer Myths: What Really Fuels Cancer Growth? W/ Dr. Seyfried and Dr. Fung
01:22:31
Professor Thomas Seyfried: Cancer is NOT caused by "bad luck" or your genes! It's mitochondrial!
28:31
Interview with Thomas Seyfried about Prostate Cancer Metabolism and Ketogenic Diet
01:18:07

Joe Tippins Cancer Protocol

Joe Tippins' main treatment protocol for fenbendazole is relatively simple and easy

  1. 1 Gram (1 packet) of Panacur C is advised to be taken seven days a week. It is recommended that it should be taken with a meal.

  2.  600mg tablets of this Curcumin (turmeric) per day are recommended. This should be taken seven days a week. It also helps by increasing the p53 levels in the body.

  3. 25mg of CBD oil everyday. (Each dropper is graduated which allows for easy dosing). To be taken sublingually, under the tongue.

  4. Berberine helps in starving and weakening of the cancer cells, so it is recommended to take it 2-3 times a day

  5. Quercetin is recognized as an anti-inflammation agent, and it is recommended to be taken daily.

https://deeprootsathome.com/joe-tippins-fenbendazole-protocol/                        

https://duckduckgo.com/?t=ffab&q=tiredness+during+Joe+Tippen’s+protocol%3F+&iax=videos&ia=videos

More Doctors and Cancer

Dr. Berg

Dr. Jones
Veterinarian Dog Cancer

Dr. John Campbell

20 Success Story Articles by Dr. William Makis on Fenbendazole/Ivermectin for Cancer

  1. IVERMECTIN and FENBENDAZOLE Testimonial - 65-year-old Swedish Man with Recurrent Bladder Cancer
    Recurrent bladder cancer declared "cancer-free" after 2.5 years; started ivermectin (1mg/kg/day) and fenbendazole (444mg/day) in Jan 2025; clean cystoscopy and CT scans after 3 months.

  2. IVERMECTIN and FENBENDAZOLE Testimonial - 40-year-old Canadian with Stage 4 Pancreatic Cancer
    Stage 4 pancreatic cancer with liver mets; after 3.5 months on ivermectin (1.5mg/kg/day) and fenbendazole (1000mg/day), all lesions shrinking, CA19-9 tumor marker down 98%.

  3. IVERMECTIN and FENBENDAZOLE Testimonial - 51-year-old UK Man with Stage 4 Colon Cancer
    Stage 4 colon cancer metastatic to peritoneum; amazing results after 2.5 months on ivermectin (1mg/kg/day) and fenbendazole (444mg/day), with significant tumor reduction and improved energy.

  4. IVERMECTIN and FENBENDAZOLE Testimonials - Endometrial Cancer (Four Patients from Canada, USA, Germany)
    Four stage 3-4 endometrial cancer patients; all showed tumor shrinkage or remission after 2-4 months on ivermectin + fenbendazole combo, with one achieving NED status.

  5. IVERMECTIN and FENBENDAZOLE Testimonial - Two Blood Cancers: AML and CLL
    AML patient became "cancer-free" after 2 months; CLL patient saw first improvement in 2 years; both on ivermectin (1mg/kg/day) and fenbendazole (444mg/day).

  6. Fenbendazole Self-Administration Case Series - Three Advanced Cancer Patients
    Breast, prostate, and melanoma patients achieved complete or near-complete remission after 11-35 months on fenbendazole (222-444mg/day) with other therapies; no adverse effects.

  7. Ivermectin and Fenbendazole for Stage 4 Cholangiocarcinoma - 53-year-old Canadian
    15cm stage 4 bile duct tumor; "cancer-free" after 14 months on fenbendazole (444mg/day), ivermectin (2.5mg/kg/day), and CBD-THC; initial chemo failed.

  8. From Metastatic Cancer to Cancer-Free - Recurrence Resolved in 3 Months
    Stage 4 recurrence after palliative chemo/immunotherapy; resolved with high-dose ivermectin, fenbendazole, and melatonin; patient NED after 4.5 years from diagnosis.

  9. Ivermectin and Fenbendazole for Brain Cancer - 61-year-old Kentucky Woman with Oligodendroglioma
    Grade 2 brain tumor shrank after 5 months on ivermectin (1mg/kg/day) and fenbendazole (444mg/day); improved symptoms and scans.

  10. Ivermectin, Mebendazole, and Fenbendazole for DIPG - 5-year-old Swiss Boy
    Diffuse intrinsic pontine glioma; tumor shrinkage after 4 months on ivermectin (1mg/kg/day), mebendazole (1500mg/day), and fenbendazole (1500mg/day) .

  11. Ivermectin and Fenbendazole for Stage 4 Prostate Cancer - 68-year-old California Man
    Paraplegic from vertebral destruction; major improvement after 3 months on ivermectin (1.5mg/kg/day) and fenbendazole (1000mg/day); regained mobility.

  12. Ivermectin and Fenbendazole for Stage 4 Prostate Cancer - 69-year-old Canadian
    Liver mets improved significantly after 4 months on ivermectin (1.5mg/kg/day) and fenbendazole (1500mg/day); better energy and well-being.

  13. Ivermectin and Fenbendazole for Stage 4 Ovarian Cancer - 67-year-old WA Woman
    Almost cancer-free after 2 months on ivermectin (1mg/kg/day) and fenbendazole (444mg/day); dramatic reduction in pelvic mass and ascites.

  14. Ivermectin and Mebendazole for Stage 4 Breast Cancer - 26-year-old UK Woman
    Triple-negative with brain/lung mets; shrinking mets after 4 weeks on ivermectin (1mg/kg/day) and mebendazole (1000mg/day) .

  15. Ivermectin and Fenbendazole for Stage 4 Colorectal Cancer - 34-year-old Slovenian Man
    Liver mets almost completely resolved after 4 months on ivermectin (1mg/kg/day) and fenbendazole (444mg/day); colon mass gone .

  16. Ivermectin and Fenbendazole for Stage 4 Appendix Goblet Cell Cancer - 47-year-old WA Woman
    Peritoneal mets improved after 4 months on ivermectin (1mg/kg/day) and fenbendazole (1000mg/day); CEA marker halved.

  17. Ivermectin and Fenbendazole for Stage 4 Colorectal Cancer - 49-year-old SC Woman
    Liver tumors almost completely gone after 5 months on ivermectin (1mg/kg/day) and fenbendazole (444mg/day); CEA down 90% .

  18. Ivermectin and Fenbendazole for Stage 4 Colon Cancer - 37-year-old Portuguese Woman
    Lung mets reduced after 6 months on ivermectin (1mg/kg/day) and fenbendazole (444mg/day); improved quality of life.

  19. Ivermectin and Fenbendazole for Stage 4 Colon Signet Ring - 62-year-old CT Man
    Peritoneal disease stable/improving after 3 months on ivermectin (1.5mg/kg/day) and fenbendazole (1000mg/day); CEA normalized.

  20. Ivermectin and Fenbendazole for Stage 4 Pancreatic Head Cancer - 67-year-old Woman
    Pancreatic mass and liver lesions gone after 2.5 months on ivermectin (1mg/kg/day) and fenbendazole (444mg/day); now cancer-free post-FOLFIRINOX failure.

Various Youtube Videos on Cancer

Mushroom, Tincture is among the best source

Caner, Anti-Cancer Properties

Turkey Tail Mushroom tincture 4 dropper, 4ml per serving up to 1 time a day

Reishi Mushroom tincture 4 dropper, 4ml, per serving up to 1 time a day.

Stelfonta

New drug from "Blushwood Berry" cancer drug for dogs

"Blushwood Berry" for People? Extract available from link.

https://blushwood.health/products/blushwood-berry-extract-capsules

The drug is made extracting a compound out of the Blushwood Berry seed, a plant native to Australia. Eating the fruit and the seeds has similar effects based on comments I have read.​

https://www.abc.net.au/news/2014-10-07/queensland-scientists-discover-cancer-fighting-berry/5796106#

https://news.stanford.edu/stories/2022/10/breakthrough-production-acclaimed-cancer-treating-drug

Extra Cancer Reserarch

Dog Vet Cancer Research

Drug Panacur/Fenbendazole, Ivermectin, dog dewormer, people and dogs are also utitlizing in cancer treatment.

Extra Cancer Research
How to Use Powerful Mushrooms to Naturally Improve Pet Health
41:04
Medicinal Mushrooms for Dog Cancer Part 2 | Dr. Robert Silver
33:01
Is Joe Tippens Still Cancer Free?
05:57
Ivermectin for Cancer in Dogs: Doses and Regimens
08:07
Starving Cancer: Breaking Down Thomas Seyfried's Radical & Controversial Protocol
02:38:08
Berberine, Curcumin & Milk Thistle BLOCK Glutamine Uptake
14:46
Medicinal Mushrooms For Dogs & The Problem With Mycelium
06:09
Medicinal Mushrooms for Dog Cancer Part 1 | Dr. Robert Silver
31:31
Help Your Dog's and Cat's Cancer with Medicinal Mushrooms
09:53

Note: 1kg is equal to 2.2 lbs.

Dosing and testing

Fenbendazole has been studied extensively in animals for safety and toxicity, with some emerging research on its potential anti-cancer effects in humans. Here's a summary of key findings on fenbendazole dosage levels and safety studies:

 
Animal Studies
Safety Profile

 

Fenbendazole has demonstrated a high safety margin in animal studies:

 

- In cattle, it was well-tolerated even at six times the prescribed dose and three times the recommended duration [1].

- In rodents, the lethal dose (LD50) exceeded 10 g/kg, which is 1,000 times the therapeutic level [1].

- Lifetime studies in rats showed no maternal or reproductive toxicity and no carcinogenesis, though some morphologic changes in hepatocellular  

   hypertrophy and hyperplasia were observed [1].

 

Dosage Studies

 

- In swine, a safety study using doses of 0, 3, 9, 15, and 25 mg/kg body weight for 3 days revealed no significant adverse effects [5].

- In rats, a 15-week study used doses of 160, 400, or 1000 mg/kg body weight/day. Some weight gain differences were noted, but no significant toxicity

  was reported [4].

- In dogs, a 6-month study used doses of 0, 20, 50, and 125 mg/kg body weight/day. Some effects were observed even at the lowest dose of 20

  mg/kg/day [4].  THESE ARE VERY HIGH DOSES

 

Human Studies

 

While human studies are limited, some information is available:

 

- A phase I study of oxfendazole (a major metabolite of fenbendazole) in healthy participants found acceptable safety and tolerability profiles for doses

  up to 15 mg/kg/day for 5 days [1].

- Some cancer researchers have proposed protocols using 222-444 mg of fenbendazole daily for cancer treatment, though these are not yet supported

  by clinical trials [6].

 
Potential Toxicity

 

While generally considered safe, some studies have noted potential concerns:

 

- Myelosuppression has been reported as a side effect in various species, including birds, reptiles, and mammals [2].

- In rabbits, toxicosis including lethargy, hemorrhage, and death were reported in some cases, especially with high doses or prolonged administration [2].

- In mice, fenbendazole treatment affected bone marrow cells, particularly B cells [2].

 

Considerations for Cancer Treatment

 

While some researchers are exploring fenbendazole's potential anti-cancer effects, it's important to note:

 

- Clinical trials in humans for cancer treatment are still lacking [6].

- The mechanisms by which fenbendazole might affect cancer cells include triggering apoptosis, restricting glucose uptake, and reactivating tumor

  suppressor genes [6].

- Proposed protocols for cancer treatment are not yet validated by rigorous clinical studies [6].

 

In conclusion, while fenbendazole has shown a good safety profile in animal studies, its use in humans, especially for cancer treatment, requires further research and clinical trials to establish safe and effective dosage levels. Any use of fenbendazole outside its approved indications should be done under close medical supervision.

Citations:

[1] https://ar.iiarjournals.org/content/44/9/3725

[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC9413524/

[3] https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/fenbendazole

[4] https://www.inchem.org/documents/jecfa/jecmono/v29je04.htm

[5] https://pubmed.ncbi.nlm.nih.gov/6870017/

[6] https://internalhealingandwellnessmd.com/fenbendazole-for-cancer/

Could This Dog Dewormer Cure CANCER? | Dr. Jones Explains
11:38
Edmond man says cheap drug for dogs cured his cancer
03:46
FENBENDAZOLE & ARTEMISININ I The Common Sense MD I Dr. Tom Rogers
17:16

Note: 1kg is equal to 2.2 lbs.

Dosing and testing

Based on the search results, here is a summary of key findings on ivermectin dosage levels, safety, and toxicity from medical studies:

 

Safety Profile and Dosage Studies

 

- Ivermectin has demonstrated a high safety margin in animal and human studies, even at doses much higher than the FDA-approved dose of 200

   μg/kg[1][2].

- A clinical trial found ivermectin was generally well-tolerated at doses up to 10 times the FDA-approved maximum dose, with no indication of associated

  CNS toxicity [2].

- Studies have shown single doses up to 120 mg (about 2000 μg/kg) and repeated doses of 60 mg (about 1000 μg/kg) three times weekly were safe

  and well-tolerated in healthy volunteers [1][2].

- A phase III study examining 200–400 μg/kg daily doses for 3 days in dengue fever patients demonstrated safety [1].

 

Toxicity and Adverse Events

 

- Animal models generally report toxic doses between 5-15 mg/kg [3].

- Poison control suggests individuals who have received more than 2 mg/kg should be seen in a hospital [3].

- At higher doses, ivermectin may cross the blood-brain barrier and cause neurological symptoms [3].

- Common adverse events at therapeutic doses are typically mild and self-resolving, including nausea, dizziness, headaches, and rash [1].

- More severe adverse events are rare but may include cognitive impairment, visual disturbances, and dizziness at higher doses [5].

 

Considerations for Higher Doses

 

- While higher doses have shown good tolerability in some studies, they may increase the risk of adverse events and should be carefully monitored

  [1][5].

- The safety of long-term use of high-dose ivermectin has not been well-established [7].

- Factors such as age, liver function, and potential drug interactions should be considered when determining appropriate dosing [8].

 

Citations:

[1] https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-022-00645-8

[2] https://pubmed.ncbi.nlm.nih.gov/12362927/

[3] https://www.ems1.com/coronavirus-covid-19/articles/understanding-ivermectin-I6HFMGuIN9stMjii/

[4] https://pubmed.ncbi.nlm.nih.gov/36374218/

[5] https://jamanetwork.com/journals/jama/article-abstract/2801827

[6] https://www.researchprotocols.org/2016/4/e213

[7] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775035/

[8] https://www.medicalnewstoday.com/articles/ivermectin-oral-tablet

 

1. **Antitumor Effects**: Studies have shown that ivermectin can inhibit tumor growth in various cancer models, including leukemia, glioblastoma, breast cancer, and osteosarcoma. The antitumor effects are thought to be due to its ability to modulate several pathways, such as the multidrug resistance protein (MDR), Akt/mTOR, and WNT-TCF pathways[1][2].

 

2. **Dosing in Research**: The doses used in preclinical studies vary widely. For example:

   - In mice models, doses ranged from 0.5 mg/kg to 5 mg/kg administered intraperitoneally or orally[1][3].

   - In vitro studies often use concentrations ranging from 0.2 µM to 10 µM[5].

 

3. **Combination Therapies**: Ivermectin has been studied in combination with other cancer treatments, such as chemotherapy drugs like doxorubicin and immune checkpoint inhibitors like anti-PD1 antibodies. These combinations have shown enhanced efficacy compared to single treatments alone[2][3].

 

4. **Human Dosing Considerations**: While some studies suggest that doses up to 2 mg/kg are tolerable in humans based on pharmacokinetic studies, these findings are primarily derived from its use as an antiparasitic agent[2]. There is no approved dosing regimen for cancer treatment in humans.

 

Clinical Implications

 

Despite promising preclinical results, ivermectin's use as a cancer treatment is not yet clinically validated or approved. The research is ongoing, and further studies are needed to determine safe and effective dosing regimens for cancer patients. It is crucial for patients to follow medical advice and not self-medicate with ivermectin for cancer treatment without professional guidance.

 

In summary, while ivermectin shows potential as part of a cancer treatment strategy, its application in oncology remains experimental and should be approached with caution until more definitive clinical evidence is available.

 

Citations:

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC5835698/

[2] https://journals.sagepub.com/doi/10.1177/09603271221143693

[3] https://www.nature.com/articles/s41523-021-00229-5

[4] https://pmc.ncbi.nlm.nih.gov/articles/PMC10054244/

[5] https://www.spandidos-publications.com/10.3892/mmr.2017.8231

Notes from Video

Humans: In healthy volunteers the dose was increased to two milligrams per 1 kilogram equal to 22lbs and no serious adverse reactions were found.

Animals: Tests in animals such as mice rats and rabbits found that the median lethal dose of ivermectin was 10 to 50 milligrams per 1 kilogram equal to 22lbs very high dose.

Ivermectin for Cancer?
29:02
Ivermectin and Cancers
15:23
Ivermectin for Cancer in Dogs: Doses and Regimens
08:07

***FOR EDUCATIONAL PURPOSES ONLY, CONSULT YOUR OWN MEDICAL DOCTOR***

***NOT A RECOMMENDATION, NOT MEDICAL ADVICE, DO YOUR OWN RESEARCH, GET EDUCATED!***

MEDICAL DISCLAIMER: This content is for informational purposes only and does not constitute medical advice. Never disregard or delay professional medical care based on this information. The information presented should not replace consultation with qualified healthcare providers. We are not liable for any adverse effects resulting from the use of this content. Always consult your healthcare provider before making any health-related decisions. No content here should be used for medical diagnosis or treatment.

bottom of page